Roberto Assandri

438 total citations
23 papers, 230 citations indexed

About

Roberto Assandri is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Roberto Assandri has authored 23 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Roberto Assandri's work include Biomarkers in Disease Mechanisms (7 papers), COVID-19 Clinical Research Studies (5 papers) and Microscopic Colitis (3 papers). Roberto Assandri is often cited by papers focused on Biomarkers in Disease Mechanisms (7 papers), COVID-19 Clinical Research Studies (5 papers) and Microscopic Colitis (3 papers). Roberto Assandri collaborates with scholars based in Italy, Finland and Japan. Roberto Assandri's co-authors include Alessandro Montanelli, Michele Mazzanti, Marta Monari, Dario DiFrancesco, A Ferroni, Ciro Canetta, Elisabetta Buscarini, Alessandro Scartabellati, A. Colombo and Federico Serana and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Frontiers in Immunology.

In The Last Decade

Roberto Assandri

23 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Assandri Italy 9 71 55 53 43 35 23 230
Francisco Morandeira Spain 10 37 0.5× 53 1.0× 39 0.7× 13 0.3× 75 2.1× 29 241
Jalel Chemli Tunisia 11 73 1.0× 137 2.5× 48 0.9× 13 0.3× 96 2.7× 44 359
Meera V. Singh United States 10 91 1.3× 79 1.4× 57 1.1× 13 0.3× 34 1.0× 24 354
Sofie Nilsson-Ardnor Sweden 5 52 0.7× 133 2.4× 92 1.7× 35 0.8× 29 0.8× 7 333
Rajat Lahoria United States 8 68 1.0× 42 0.8× 10 0.2× 26 0.6× 122 3.5× 14 283
Amichai Schattner Israel 7 49 0.7× 110 2.0× 26 0.5× 19 0.4× 58 1.7× 17 278
Ritu Agarwal India 8 32 0.5× 32 0.6× 23 0.4× 17 0.4× 92 2.6× 25 306
Kyung-Sue Shin South Korea 8 71 1.0× 87 1.6× 20 0.4× 13 0.3× 47 1.3× 20 254
Asha Shenoy India 9 106 1.5× 48 0.9× 20 0.4× 7 0.2× 58 1.7× 34 337
Serra E. Elliott United States 8 33 0.5× 77 1.4× 32 0.6× 17 0.4× 12 0.3× 11 229

Countries citing papers authored by Roberto Assandri

Since Specialization
Citations

This map shows the geographic impact of Roberto Assandri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Assandri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Assandri more than expected).

Fields of papers citing papers by Roberto Assandri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Assandri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Assandri. The network helps show where Roberto Assandri may publish in the future.

Co-authorship network of co-authors of Roberto Assandri

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Assandri. A scholar is included among the top collaborators of Roberto Assandri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Assandri. Roberto Assandri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Assandri, Roberto, et al.. (2022). Long pentraxin 3 as a marker of COVID-19 severity: evidences and perspectives. University of Zagreb University Computing Centre (SRCE). 11 indexed citations
2.
Ceribelli, Angela, Natasa Isailovic, Roberto Assandri, et al.. (2022). Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease. Frontiers in Immunology. 13. 822996–822996. 6 indexed citations
3.
Gili, Tommaso, Elisabetta Buscarini, Ciro Canetta, et al.. (2021). SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy. PLoS ONE. 16(3). e0248498–e0248498. 21 indexed citations
4.
Assandri, Roberto & Alessandro Montanelli. (2021). Acute severe autoimmune hepatitis with anti-rods and rings autoantibodies; literature first evidence.. PubMed. 14(1). 89–94. 2 indexed citations
5.
Canetta, Ciro, Elisabetta Buscarini, Alessandro Scartabellati, et al.. (2020). Syncope at SARS-CoV-2 onset. Autonomic Neuroscience. 229. 102734–102734. 14 indexed citations
6.
Assandri, Roberto, et al.. (2020). Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room. Archives of Medical Research. 51(6). 598–599. 26 indexed citations
7.
Assandri, Roberto. (2019). Primary biliary cholangitis with contemporary presence of anti-mithocondrial and anti-rods and rings autoantibodies: literature first case.. PubMed. 12(1). 76–82. 6 indexed citations
8.
Assandri, Roberto & Alessandro Montanelli. (2019). Diagnosis of gluten-related enteropathy in a newborn: how and when?. PubMed. 12(4). 278–286. 3 indexed citations
9.
Assandri, Roberto & Alessandro Montanelli. (2018). Pentraxin 3 and biopsy status in celiac patients.. PubMed. 11(3). 225–232. 1 indexed citations
10.
Assandri, Roberto, Federico Serana, & Alessandro Montanelli. (2017). Development of PBC/SSc overlap syndrome in chronic GVHD patient: immunological implications in the presence of mitochondrial, nucleolar and spindle midzone autoantigens.. PubMed. 10(4). 323–331. 5 indexed citations
11.
Assandri, Roberto, Marta Monari, & Alessandro Montanelli. (2016). Development of systemic sclerosis in patients with autoimmune hepatitis: an emerging overlap syndrome.. PubMed. 9(3). 211–9. 13 indexed citations
12.
Assandri, Roberto, Marta Monari, A. Colombo, & Alessandro Montanelli. (2015). Pentraxin 3 Serum Levels in Celiac Patients: Evidences and Perspectives. Recent Patents on Food Nutrition & Agriculture. 6(2). 82–92. 4 indexed citations
13.
Ristagno, Giuseppe, Tero Varpula, Serge Masson, et al.. (2015). Elevations of inflammatory markers PTX3 and sST2 after resuscitation from cardiac arrest are associated with multiple organ dysfunction syndrome and early death. Clinical Chemistry and Laboratory Medicine (CCLM). 53(11). 1847–57. 22 indexed citations
14.
Assandri, Roberto & Marta Monari. (2015). Pentraxin 3 in Systemic Lupus Erithematosus: Questions to be Resolved. 6(1). 1 indexed citations
15.
Assandri, Roberto, et al.. (2015). Pentraxin 3 Plasma Levels and Disease Activity in Systemic Lupus Erythematosus. Autoimmune Diseases. 2015. 1–8. 20 indexed citations
16.
Assandri, Roberto, Marta Monari, A. Colombo, & Alessandro Montanelli. (2015). Innate immune system: the no man's land where discover new biomarkers for gluten-related-disorders.. PubMed. 8(2). 95–8. 2 indexed citations
17.
Alpini, Claudia, et al.. (2011). [Anti-Golgi antibodies: let me look around].. PubMed. 102(1). 11–3. 5 indexed citations
18.
Monari, Marta, et al.. (2010). HIV 1-2 Ag/Ab selective and combined detection by a new rapid point-of-care test. Microbiologia medica. 25(4). 1 indexed citations
19.
Assandri, Roberto & Michele Mazzanti. (1997). Ionic Permeability on Isolated Mouse Liver Nuclei: Influence of ATP and Ca 2+. The Journal of Membrane Biology. 157(3). 301–309. 25 indexed citations
20.
Mazzanti, Michele, Roberto Assandri, A Ferroni, & Dario DiFrancesco. (1996). Cytoskeletal control of rectification and expression of four substates in cardiac inward rectifier K + channels. The FASEB Journal. 10(2). 357–361. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026